{"public_id":"co_c8a9a2c1c9a7ade3a48ac179d1d425cd","status":"active","merged_into_public_id":null,"resolved_public_id":"co_c8a9a2c1c9a7ade3a48ac179d1d425cd","name":"apatinib combined with homoharringtonine","description":"The drug combination of apatinib and homoharringtonine tested for antileukemia activity.","aliases":["Apatinib and HHT","Apatinib combined with HHT"],"types":["combination therapy"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":251998037,"title":"Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia","citation_count":3,"url":"https://sah.borca.ai/papers/251998037"}],"claims":[{"public_id":"cl_0254c6c7fa228f55922773e13ead0ee2","text":"Apatinib and homoharringtonine suppress VEGFR-2 expression and downstream PI3K, MAPK, and STAT3 signaling cascades in acute myeloid leukemia cells.","corpus_id":251998037,"url":"https://sah.borca.ai/claims/cl_0254c6c7fa228f55922773e13ead0ee2"},{"public_id":"cl_2cb13b98a4f2c0d3e7cef8cc846f23ac","text":"VEGFR-2 is identified as a therapeutic target linked to the observed combination effect in acute myeloid leukemia cells.","corpus_id":251998037,"url":"https://sah.borca.ai/claims/cl_2cb13b98a4f2c0d3e7cef8cc846f23ac"},{"public_id":"cl_8649c323fc538e18e129e9d37a8bf55d","text":"Apatinib combined with homoharringtonine markedly inhibits proliferation, reduces colony-forming capacity, and induces apoptosis and cell cycle arrest in acute myeloid leukemia cells.","corpus_id":251998037,"url":"https://sah.borca.ai/claims/cl_8649c323fc538e18e129e9d37a8bf55d"},{"public_id":"cl_ac9b31366f8e13f0501b64650e4735ba","text":"Apatinib combined with homoharringtonine exerts a better antileukemia effect than apatinib alone in preclinical acute myeloid leukemia models.","corpus_id":251998037,"url":"https://sah.borca.ai/claims/cl_ac9b31366f8e13f0501b64650e4735ba"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_c8a9a2c1c9a7ade3a48ac179d1d425cd","url":"https://sah.borca.ai/concepts/co_c8a9a2c1c9a7ade3a48ac179d1d425cd"}